[{"address1": "7171 Rue Frederick Banting", "city": "Saint-Laurent", "state": "QC", "zip": "H4S 1Z9", "country": "Canada", "phone": "514 332 4888", "website": "https://www.engene.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Gu\u00e9rin. The company was founded in 2023 and is based in Saint-Laurent, Canada.", "fullTimeEmployees": 31, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alex  Nichols Ph.D.", "age": 37, "title": "President & COO", "yearBorn": 1986, "fiscalYear": 2023, "totalPay": 504442, "exercisedValue": 0, "unexercisedValue": 3900970}, {"maxAge": 1, "name": "Dr. James C. Sullivan M.Sc., Ph.D.", "age": 44, "title": "Chief Scientific Officer", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 524286, "exercisedValue": 0, "unexercisedValue": 2561114}, {"maxAge": 1, "name": "Mr. Ronald H. W. Cooper", "age": 60, "title": "Chief Executive Officer & Director", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anthony T. Cheung Ph.D.", "age": 51, "title": "Co-Founder & CTO", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 341754, "exercisedValue": 0, "unexercisedValue": 13448566}, {"maxAge": 1, "name": "Mr. John C. Brown D.Sc., FRSC, Ph.D.", "title": "Co-Founder and Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David Ryan Daws", "age": 49, "title": "CFO & Head of Business Development", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lee G. Giguere", "age": 42, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sharon  Tan", "title": "VP of Project Management & Head of Program Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raj  Pruthi M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Erickson", "title": "Non-Executive Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 6.98, "open": 7.0, "dayLow": 6.72, "dayHigh": 7.07, "regularMarketPreviousClose": 6.98, "regularMarketOpen": 7.0, "regularMarketDayLow": 6.72, "regularMarketDayHigh": 7.07, "beta": -0.674, "forwardPE": -4.0, "volume": 50578, "regularMarketVolume": 50578, "averageVolume": 143200, "averageVolume10days": 84020, "averageDailyVolume10Day": 84020, "bid": 6.59, "ask": 7.09, "bidSize": 100, "askSize": 100, "marketCap": 296796864, "fiftyTwoWeekLow": 4.938, "fiftyTwoWeekHigh": 47.17, "fiftyDayAverage": 7.869, "twoHundredDayAverage": 10.768855, "currency": "USD", "enterpriseValue": 56670588, "floatShares": 11301237, "sharesOutstanding": 44166200, "sharesShort": 119039, "sharesShortPriorMonth": 171741, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0027, "heldPercentInsiders": 0.13344, "heldPercentInstitutions": 0.94541, "shortRatio": 0.79, "shortPercentOfFloat": 0.0038, "bookValue": 5.502, "priceToBook": 1.221374, "lastFiscalYearEnd": 1698710400, "nextFiscalYearEnd": 1730332800, "mostRecentQuarter": 1714435200, "netIncomeToCommon": -115345000, "trailingEps": -2.61, "forwardEps": -1.68, "enterpriseToEbitda": -1.273, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ENGN", "underlyingSymbol": "ENGN", "shortName": "enGene Holdings Inc.", "longName": "enGene Holdings Inc.", "firstTradeDateEpochUtc": 1643725800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f9f4e2ed-4011-3f93-916a-f8a188a8b358", "gmtOffSetMilliseconds": -14400000, "currentPrice": 6.72, "targetHighPrice": 40.0, "targetLowPrice": 27.0, "targetMeanPrice": 32.14, "targetMedianPrice": 30.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 264810000, "totalCashPerShare": 5.996, "ebitda": -44523000, "totalDebt": 24684000, "quickRatio": 42.233, "currentRatio": 42.802, "debtToEquity": 10.159, "operatingCashflow": -35608000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-04"}]